Archive: 29/03/2013

US OKs first-of-its-kind diabetes drug (Update)

The U.S. Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar—flushing it out in patients' urine.

Fringe therapy may help heart patients, study finds

A treatment that removes heavy metals from the body has long been touted as an alternative therapy to combat hardening arteries. Now a 10-year, $31 million clinical trial has found that chelation therapy does help heart attack ...

page 1 from 3